Page 256 - Vitamin D and Cancer

10 Vitamin D and Prostate Cancer 243

41. Mikhak B, Hunter DJ, Spiegelman D et al (2007) Vitamin D receptor (VDR) gene polymor-
phisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1, 25-dihydroxyvi-
tamin D, and prostate cancer risk. Prostate 67:911–923
42. Whitfield GK, Remus LS, Jurutka PW et al (2001) Functionally relevant polymorphisms in
the human nuclear vitamin D receptor gene. Mol Cell Endocrinol 177:145–159
43. Campbell MJ, Elstner E, Holden S et al (1997) Inhibition of proliferation of prostate cancer
cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1,
p27kip1 and E-cadherin. J Mol Endocrinol 19:15–27
44. Sheikh MS, Rochefort H, Garcia M (1995) Overexpression of p21WAF1/CIP1 induces
growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines.
Oncogene 11:1899–1905
45. Wang QM, Jones JB, Studzinski GP (1996) Cyclin-dependent kinase inhibitor p27 as a
mediator of the G1-S phase block induced by 1, 25-dihydroxyvitamin D3 in HL60 cells.
Cancer Res 56:264–267
46. Zhuang SH, Burnstein KL (1998) Antiproliferative effect of 1alpha, 25-dihydroxyvitamin
D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase
2 activity and persistent G1 accumulation. Endocrinology 139:1197–1207
47. Tong WM, Kallay E, Hofer H et al (1998) Growth regulation of human colon cancer cells by
epidermal growth factor and 1, 25-dihydroxyvitamin D3 is mediated by mutual modulation
of receptor expression. Eur J Cancer 34:2119–2125
48. Matsumoto K, Hashimoto K, Nishida Y et al (1990) Growth-inhibitory effects of 1,
25-dihydroxyvitamin D3 on normal human keratinocytes cultured in serum-free medium.
Biochem Biophys Res Commun 166:916–923
49. Reitsma PH, Rothberg PG, Astrin SM et al (1983) Regulation of myc gene expression in
HL-60 leukaemia cells by a vitamin D metabolite. Nature 306:492–494
50. Capiati DA, Rossi AM, Picotto G et al (2004) Inhibition of serum-stimulated mitogen activated
protein kinase by 1alpha, 25(OH)2-vitamin D3 in MCF-7 breast cancer cells. J Cell Biochem
93:384–397
51. Park WH, Seol JG, Kim ES et al (2000) Induction of apoptosis by vitamin D3 analogue
EB1089 in NCI-H929 myeloma cells via activation of caspase 3 and p38 MAP kinase. Br J
Haematol 109:576–583
52. Peehl DM, Skowronski RJ, Leung GK et al (1994) Antiproliferative effects of 1, 25- dihydroxyvitamin
D3 on primary cultures of human prostatic cells. Cancer Res 54:805–810
53. Oades GM, Dredge K, Kirby RS et al (2002) Vitamin D receptor-dependent antitumour
effects of 1, 25-dihydroxyvitamin D3 and two synthetic analogues in three in vivo models of
prostate cancer. BJU Int 90:607–616
54. Whitlatch LW, Young MV, Schwartz GG et al (2002) 25-Hydroxyvitamin D-1alpha-
hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene
transfer. J Steroid Biochem Mol Biol 81:135–140
55. Getzenberg RH, Light BW, Lapco PE et al (1997) Vitamin D inhibition of prostate adenocarci-
noma growth and metastasis in the Dunning rat prostate model system. Urology 50:999–1006
56. Lokeshwar BL, Schwartz GG, Selzer MG et al (1999) Inhibition of prostate cancer metasta-
sis in vivo: a comparison of 1, 23-dihydroxyvitamin D (calcitriol) and EB1089. Cancer
Epidemiol Biomarkers Prev 8:241–248
57. Yudoh K, Matsuno H, Kimura T (1999) 1alpha, 25-dihydroxyvitamin D3 inhibits in vitro
invasiveness through the extracellular matrix and in vivo pulmonary metastasis of B16
mouse melanoma. J Lab Clin Med 133:120–128
58. Schwartz GG, Hill CC, Oeler TA et al (1995) 1, 25-Dihydroxy-16-ene-23-yne-vitamin D3
and prostate cancer cell proliferation in vivo. Urology 46:365–369
59. Schwartz GG, Oeler TA, Uskokovic MR et al (1994) Human prostate cancer cells: inhibition
of proliferation by vitamin D analogs. Anticancer Res 14:1077–1081
60. Bao BY, Yeh SD, Lee YF (2006) 1alpha, 25-dihydroxyvitamin D3 inhibits prostate cancer
cell invasion via modulation of selective proteases. Carcinogenesis 27:32–42
61. Schwartz GG, Wang MH, Zang M et al (1997) 1 alpha, 25-Dihydroxyvitamin D (calcitriol) inhibits
the invasiveness of human prostate cancer cells. Cancer Epidemiol Biomarkers Prev 6:727–732